A bipartisan House bill introduced Friday afternoon would add all sorts of new transparency measures around healthcare and serve up major PBM reforms as members of Congress on both sides of the aisle look to shake up the way pharma middlemen operate.
The 231-page bill, known as the Click here to view original post
